HomeIXC • ASX
add
Invex Therapeutics Ltd
Previous close
$0.060
Year range
$0.060 - $0.090
Market cap
4.51M AUD
Avg Volume
24.19K
P/E ratio
38.22
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 236.09K | -81.03% |
Net income | -178.27K | 83.12% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.81M | -5.61% |
Total assets | 5.86M | -6.63% |
Total liabilities | 479.87K | -51.26% |
Total equity | 5.38M | — |
Shares outstanding | 75.15M | — |
Price to book | 0.86 | — |
Return on assets | -10.06% | — |
Return on capital | -10.96% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -178.27K | 83.12% |
Cash from operations | -120.81K | 89.57% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -109.30K | 98.66% |
Free cash flow | -139.41K | 80.60% |
About
Founded
2019
Website
